Cargando…
A cost-utility and budget impact analysis of allogeneic hematopoietic stem cell transplantation for severe thalassemic patients in Thailand
BACKGROUND: Hematopoietic stem cell transplantation (HSCT) is the only curative treatment available to severe thalassemic patients. The treatment, however, is very costly, particularly in the context of low and middle income countries, and no studies have been carried out to explore its economic jus...
Autores principales: | Leelahavarong, Pattara, Chaikledkaew, Usa, Hongeng, Suradej, Kasemsup, Vijj, Lubell, Yoel, Teerawattananon, Yot |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2914036/ https://www.ncbi.nlm.nih.gov/pubmed/20633303 http://dx.doi.org/10.1186/1472-6963-10-209 |
Ejemplares similares
-
A cost-utility analysis of drug treatments in patients with HBeAg-positive chronic hepatitis B in Thailand
por: Tantai, Narisa, et al.
Publicado: (2014) -
The use of comparative effectiveness research to inform policy decisions on the inclusion of bevacizumab for the treatment of macular diseases in Thailand’s pharmaceutical benefit package
por: Anothaisintawee, Thunyarat, et al.
Publicado: (2012) -
Variation of health-related quality of life assessed by caregivers and patients affected by severe childhood infections
por: Kulpeng, Wantanee, et al.
Publicado: (2013) -
The economic costs of alcohol consumption in Thailand, 2006
por: Thavorncharoensap, Montarat, et al.
Publicado: (2010) -
A real-world study of effectiveness of intravitreal bevacizumab and ranibizumab injection for treating retinal diseases in Thailand
por: Kumluang, Suthasinee, et al.
Publicado: (2019)